Overall, this work contributes to the growing body of evidence exploring the unique and common pathophysiological effects of different CaM variant-mediated arrhythmias, aiding the development of more effective treatments for patients with these disorders. The gene discussed is CALM2; the disease is cardiac arrhythmia.